Skip to content

Clinical trials

Phase 2 Multiple Sclerosis, Relapsing-Remitting trials in Spain

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Multiple Sclerosis, Relapsing-Remitting Phase: Phase 2 Country / region: Spain Clear all

20 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20041
20051
20081
20092
20102
20113
20135
20161
20172
20181
20201

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed13
Terminated6
Active, not recruiting1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Novartis Pharmaceuticals4
GlaxoSmithKline3
Biogen2
GeNeuro SA2
Tanabe Pharma Corporation2
Boston Scientific Corporation1
EMD Serono1
EMD Serono Research & Development Institute, Inc.1
Genentech, Inc.1
Judit Pich1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Multiple Sclerosis, Relapsing-Remitting20
Multiple Sclerosis9
Demyelinating Diseases3
Autoimmune Diseases1
Camurati-Engelmann Syndrome1
Diffuse Cerebral Sclerosis of Schilder1
Immune System Diseases1
Multiple Sclerosis, Chronic Progressive1
Nervous System Diseases1
Neuromyelitis Optica1

Trials

Showing 1 to 20 of 20. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.